Verition Fund Management’s Longevity Health Holdings, Inc. Common Stock XAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-339
Closed -$105K 2745
2023
Q2
$105K Hold
339
﹤0.01% 1971
2023
Q1
$103K Hold
339
﹤0.01% 1909
2022
Q4
$101K Hold
339
﹤0.01% 1851
2022
Q3
$99K Buy
+339
New +$98.9K ﹤0.01% 2625
2022
Q2
Sell
-339
Closed -$99K 3177
2022
Q1
$99K Hold
339
﹤0.01% 2434
2021
Q4
$98K Buy
+339
New +$98.8K ﹤0.01% 2346

Other funds holding XAGE

Verition Fund Management's XAGE Position: Q3 2023 in Review

Verition Fund Management sold out of Longevity Health Holdings, Inc. Common Stock (XAGE) in Q3 2023, closing a stake of 339 shares — an estimated $105K sold.

Verition Fund Management first reported a position in XAGE in Q4 2021 and held it in 6 quarters. The position peaked at $105K in Q2 2023. 14 funds tracked by Wall St. Rank hold XAGE as of Q3 2023.

  • Verition Fund Management reported no remaining Longevity Health Holdings, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Verition Fund Management sold 339 Longevity Health Holdings, Inc. Common Stock shares in Q3 2023, an estimated $105K.
  • Verition Fund Management first reported a position in Longevity Health Holdings, Inc. Common Stock in Q4 2021 and held it in 6 quarters.
  • Verition Fund Management's Longevity Health Holdings, Inc. Common Stock position peaked at $105K in Q2 2023.
  • 14 funds tracked by Wall St. Rank held Longevity Health Holdings, Inc. Common Stock as of Q3 2023.

Based on Verition Fund Management's 13F filing for Q3 2023, filed 14 Nov 2023.